Read + Share
Amedeo Smart
Independent Medical Education
. Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J 2024 Apr 17:ehae227. doi: 10.1093.PMID: 38630622
Email
LinkedIn
Facebook
Twitter
Privacy Policy